| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.691 | 0.01 | 0.691 | Thyroid hormone antagonist | 0.637 0.015 CID_154699897 0.283 0.103 CID_154699925 | ||
| 0.68 | 0.011 | 0.68 | Thyroid hormone beta antagonist | 0.619 0.016 CID_154699897 0.27 0.105 CID_154699925 | ||
| 0.65 | 0.001 | 0.65 | Electrolyte absorption antagonist | 0.529 0.002 CID_154699897 0.452 0.003 CID_154699925 | ||
| 0.522 | 0.007 | 0.522 | Diuretic | 0.512 0.007 CID_154699897 0.342 0.017 CID_154699925 | ||
| 0.524 | 0.016 | 0.524 | Lipoxygenase inhibitor | 0.346 0.052 CID_154699897 0.304 0.07 CID_154699925 | ||
| 0.521 | 0.037 | 0.521 | Prostaglandin dehydrogenase inhibitor | 0.404 0.066 CID_154699897 | ||
| 0.493 | 0.02 | 0.493 | Interleukin antagonist | 0.481 0.021 CID_154699897 0.434 0.026 CID_154699925 | ||
| 0.466 | 0.005 | 0.466 | Interleukin 1 antagonist | 0.464 0.005 CID_154699897 0.319 0.009 CID_154699925 | ||
| 0.479 | 0.045 | 0.479 | 15-Lipoxygenase inhibitor | 0.277 0.145 CID_154699897 | ||
| 0.442 | 0.055 | 0.442 | 5 Hydroxytryptamine release inhibitor | 0.315 0.149 CID_154699897 | ||
| 0.437 | 0.073 | 0.443 | Cyclophilin D inhibitor | 0.382 0.101 CID_154699897 0.443 0.07 CID_154699925 | CID_154699925 | |
| 0.368 | 0.018 | 0.368 | Dual specificity phosphatase 3 inhibitor | 0.247 0.041 CID_154699897 0.237 0.045 CID_154699925 | ||
| 0.358 | 0.019 | 0.358 | Non-steroidal antiinflammatory agent | 0.234 0.05 CID_154699897 0.187 0.082 CID_154699925 | ||
| 0.437 | 0.105 | 0.437 | DNA polymerase beta inhibitor | |||
| 0.321 | 0.002 | 0.321 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.105 0.005 CID_154699897 0.249 0.003 CID_154699925 | ||
| 0.322 | 0.005 | 0.322 | Uric acid excretion stimulant | 0.313 0.005 CID_154699897 0.307 0.005 CID_154699925 | ||
| 0.408 | 0.112 | 0.408 | DNA directed DNA polymerase inhibitor | |||
| 0.311 | 0.027 | 0.311 | Dual specificity phosphatase inhibitor | 0.188 0.062 CID_154699897 0.18 0.067 CID_154699925 | ||
| 0.341 | 0.065 | 0.341 | Streptokinase A inhibitor | 0.162 0.161 CID_154699897 | ||
| 0.313 | 0.049 | 0.334 | Platelet antagonist | 0.334 0.042 CID_154699897 0.292 0.055 CID_154699925 | CID_154699897 | |
| 0.328 | 0.075 | 0.328 | Cholesterol antagonist | 0.234 0.137 CID_154699897 0.271 0.111 CID_154699925 | ||
| 0.338 | 0.088 | 0.338 | Toll-Like receptor 7 agonist | 0.303 0.108 CID_154699897 | ||
| 0.327 | 0.095 | 0.327 | Toll-Like receptor agonist | 0.292 0.116 CID_154699897 | ||
| 0.251 | 0.026 | 0.251 | Cyclooxygenase inhibitor | 0.185 0.048 CID_154699897 0.149 0.071 CID_154699925 | ||
| 0.229 | 0.012 | 0.238 | Arachidonic acid antagonist | 0.213 0.022 CID_154699897 0.238 0.009 CID_154699925 | CID_154699925 | |
| 0.246 | 0.032 | 0.246 | Protein-tyrosine phosphatase inhibitor | 0.217 0.041 CID_154699897 0.173 0.061 CID_154699925 | ||
| 0.222 | 0.015 | 0.378 | Interleukin 1b antagonist | 0.378 0.005 CID_154699897 0.18 0.024 CID_154699925 | CID_154699897 | |
| 0.27 | 0.065 | 0.27 | Hypoglycemic | 0.211 0.102 CID_154699897 0.258 0.072 CID_154699925 | ||
| 0.228 | 0.026 | 0.228 | Cyclooxygenase 1 inhibitor | 0.152 0.055 CID_154699897 0.15 0.057 CID_154699925 | ||
| 0.285 | 0.086 | 0.285 | Caspase 3 stimulant | 0.233 0.128 CID_154699897 | ||
| 0.203 | 0.005 | 0.203 | Glutathione S-transferase inhibitor | 0.194 0.006 CID_154699897 0.17 0.008 CID_154699925 | ||
| 0.334 | 0.138 | 0.334 | Transcription factor inhibitor | |||
| 0.274 | 0.08 | 0.274 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.218 | 0.034 | 0.218 | Phospholipase A2 inhibitor | 0.213 0.036 CID_154699897 0.167 0.061 CID_154699925 | ||
| 0.243 | 0.07 | 0.251 | Hypolipemic | 0.251 0.067 CID_154699897 0.21 0.088 CID_154699925 | CID_154699897 | |
| 0.179 | 0.01 | 0.179 | Macrophage migration inhibitory factor inhibitor | 0.125 0.024 CID_154699897 | ||
| 0.278 | 0.116 | 0.278 | Thioredoxin glutathione reductase inhibitor | |||
| 0.229 | 0.068 | 0.229 | Pyruvate kinase inhibitor | |||
| 0.172 | 0.011 | 0.172 | Interleukin 2 antagonist | 0.148 0.019 CID_154699897 0.142 0.023 CID_154699925 | ||
| 0.204 | 0.046 | 0.231 | Succinate dehydrogenase inhibitor | 0.214 0.039 CID_154699897 0.231 0.03 CID_154699925 | CID_154699925 | |
| 0.267 | 0.115 | 0.348 | Vasodilator, peripheral | 0.348 0.074 CID_154699897 | CID_154699897 | |
| 0.213 | 0.061 | 0.213 | Insulin sensitizer | 0.181 0.095 CID_154699897 0.179 0.097 CID_154699925 | ||
| 0.173 | 0.027 | 0.173 | Expectorant | 0.161 0.031 CID_154699897 0.098 0.071 CID_154699925 | ||
| 0.216 | 0.072 | 0.216 | Anticonvulsant | 0.18 0.099 CID_154699897 | ||
| 0.165 | 0.022 | 0.165 | Sphingosine 1-phosphate receptor 4 antagonist | 0.158 0.027 CID_154699897 | ||
| 0.164 | 0.025 | 0.164 | Mucolytic | 0.156 0.029 CID_154699897 0.103 0.074 CID_154699925 | ||
| 0.145 | 0.011 | 0.145 | Prostaglandin antagonist | 0.134 0.012 CID_154699897 0.062 0.031 CID_154699925 | ||
| 0.312 | 0.181 | 0.396 | Caspase 9 stimulant | 0.291 0.204 CID_154699897 0.396 0.113 CID_154699925 | CID_154699925 | |
| 0.138 | 0.011 | 0.138 | Prostaglandin EP2 antagonist | 0.116 0.015 CID_154699897 0.063 0.039 CID_154699925 | ||
| 0.131 | 0.008 | 0.131 | Peroxisome proliferator-activated receptor gamma antagonist | 0.091 0.022 CID_154699897 0.088 0.024 CID_154699925 | ||
| 0.194 | 0.072 | 0.194 | DNA methyltransferase I inhibitor | |||
| 0.128 | 0.007 | 0.128 | NMDA receptor glycine site agonist | 0.091 0.021 CID_154699897 | ||
| 0.154 | 0.044 | 0.154 | Protein-tyrosine phosphatase 1B inhibitor | 0.153 0.044 CID_154699897 0.12 0.063 CID_154699925 | ||
| 0.193 | 0.084 | 0.193 | DNA methylase inhibitor | |||
| 0.112 | 0.005 | 0.112 | Peroxisome proliferator-activated receptor delta agonist | 0.088 0.007 CID_154699897 0.061 0.01 CID_154699925 | ||
| 0.176 | 0.07 | 0.176 | Mcl-1 antagonist | 0.133 0.108 CID_154699897 | ||
| 0.127 | 0.023 | 0.127 | Interleukin 12 antagonist | 0.117 0.032 CID_154699897 0.11 0.039 CID_154699925 | ||
| 0.122 | 0.019 | 0.122 | Peroxisome proliferator-activated receptor gamma agonist | 0.097 0.029 CID_154699897 0.097 0.029 CID_154699925 | ||
| 0.15 | 0.048 | 0.15 | Aldehyde dehydrogenase inhibitor | 0.14 0.054 CID_154699897 | ||
| 0.168 | 0.069 | 0.196 | Thrombolytic | 0.145 0.086 CID_154699897 0.196 0.054 CID_154699925 | CID_154699925 | |
| 0.112 | 0.015 | 0.112 | Aldose reductase inhibitor | 0.106 0.017 CID_154699897 0.081 0.023 CID_154699925 | ||
| 0.119 | 0.022 | 0.119 | Glutamate release inhibitor | 0.087 0.069 CID_154699897 0.093 0.056 CID_154699925 | ||
| 0.224 | 0.127 | 0.224 | 12-Lipoxygenase inhibitor | |||
| 0.1 | 0.005 | 0.1 | Prostaglandin agonist | 0.053 0.009 CID_154699897 0.032 0.02 CID_154699925 | ||
| 0.11 | 0.016 | 0.11 | NMDA receptor agonist | 0.074 0.033 CID_154699897 | ||
| 0.093 | 0.005 | 0.093 | Prostacyclin antagonist | 0.09 0.005 CID_154699897 0.081 0.005 CID_154699925 | ||
| 0.098 | 0.01 | 0.098 | Plasminogen activator inhibitor antagonist | 0.064 0.021 CID_154699897 0.047 0.036 CID_154699925 | ||
| 0.128 | 0.042 | 0.128 | Estrogen antagonist | 0.124 0.047 CID_154699897 0.125 0.046 CID_154699925 | ||
| 0.089 | 0.004 | 0.089 | Prostaglandin E2 agonist | 0.038 0.008 CID_154699897 0.023 0.017 CID_154699925 | ||
| 0.119 | 0.036 | 0.119 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.088 | 0.009 | 0.088 | Thromboxane synthase inhibitor | 0.082 0.011 CID_154699897 0.066 0.021 CID_154699925 | ||
| 0.095 | 0.018 | 0.095 | CDC25B inhibitor | 0.076 0.032 CID_154699897 0.064 0.045 CID_154699925 | ||
| 0.128 | 0.053 | 0.128 | Microtubule formation inhibitor | 0.118 0.063 CID_154699897 | ||
| 0.078 | 0.003 | 0.078 | Integrin alpha1beta1 antagonist | 0.065 0.004 CID_154699897 0.055 0.005 CID_154699925 | ||
| 0.124 | 0.055 | 0.179 | Cystathionine beta-synthase inhibitor | 0.115 0.062 CID_154699897 0.179 0.03 CID_154699925 | CID_154699925 | |
| 0.231 | 0.163 | 0.231 | Calpain 2 inhibitor | |||
| 0.096 | 0.029 | 0.101 | Leukotriene synthesis inhibitor | 0.101 0.026 CID_154699897 | CID_154699897 | |
| 0.133 | 0.068 | 0.133 | Cyclooxygenase 2 inhibitor | 0.111 0.09 CID_154699897 | ||
| 0.219 | 0.155 | 0.285 | Antithrombotic | 0.285 0.099 CID_154699897 0.229 0.144 CID_154699925 | CID_154699897 | |
| 0.067 | 0.007 | 0.067 | Peroxisome proliferator-activated receptor delta antagonist | 0.055 0.009 CID_154699897 0.055 0.009 CID_154699925 | ||
| 0.113 | 0.053 | 0.113 | DOPA decarboxylase inhibitor | 0.1 0.076 CID_154699897 | ||
| 0.141 | 0.082 | 0.141 | Cytidine deaminase inhibitor | |||
| 0.248 | 0.189 | 0.248 | Alpha-glucosidase inhibitor | |||
| 0.061 | 0.005 | 0.061 | Prostaglandin D2 antagonist | 0.06 0.005 CID_154699897 0.028 0.012 CID_154699925 | ||
| 0.075 | 0.02 | 0.075 | Peroxisome proliferator-activated receptor alpha agonist | 0.047 0.034 CID_154699897 0.046 0.035 CID_154699925 | ||
| 0.058 | 0.008 | 0.058 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.047 0.018 CID_154699897 | ||
| 0.067 | 0.018 | 0.067 | Prolyl endopeptidase inhibitor | 0.057 0.028 CID_154699897 | ||
| 0.08 | 0.032 | 0.081 | Leukotriene antagonist | 0.081 0.031 CID_154699897 0.064 0.046 CID_154699925 | CID_154699897 | |
| 0.049 | 0.006 | 0.049 | Prostaglandin EP2 agonist | 0.045 0.007 CID_154699897 0.035 0.01 CID_154699925 | ||
| 0.05 | 0.008 | 0.053 | Prostaglandin D2 agonist | 0.053 0.007 CID_154699897 0.044 0.01 CID_154699925 | CID_154699897 | |
| 0.083 | 0.043 | 0.083 | Estrogen receptor alpha antagonist | 0.076 0.055 CID_154699897 0.081 0.047 CID_154699925 | ||
| 0.099 | 0.062 | 0.099 | Nitric-oxide synthase inhibitor | |||
| 0.093 | 0.056 | 0.108 | Triose-phosphate isomerase inhibitor | 0.107 0.041 CID_154699897 0.108 0.04 CID_154699925 | CID_154699925 | |
| 0.098 | 0.061 | 0.098 | Xanthine oxidase inhibitor | 0.093 0.067 CID_154699897 | ||
| 0.042 | 0.005 | 0.042 | Prostaglandin EP4 agonist | |||
| 0.062 | 0.026 | 0.062 | Leukotriene B4 antagonist | 0.054 0.036 CID_154699897 0.052 0.04 CID_154699925 | ||
| 0.143 | 0.109 | 0.143 | Amyloid beta precursor protein antagonist | |||
| 0.135 | 0.101 | 0.135 | Interferon gamma antagonist | 0.134 0.104 CID_154699925 | ||
| 0.144 | 0.112 | 0.144 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.058 | 0.026 | 0.058 | Glucose-6-phosphate translocase inhibitor | |||
| 0.049 | 0.02 | 0.049 | NMDA receptor subunit 3A antagonist | |||
| 0.107 | 0.078 | 0.107 | Cell adhesion inhibitor | |||
| 0.057 | 0.028 | 0.057 | Beta 2 adrenoreceptor antagonist | |||
| 0.072 | 0.043 | 0.072 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.069 | 0.04 | 0.069 | Beta adrenoreceptor antagonist | 0.061 0.054 CID_154699897 | ||
| 0.097 | 0.07 | 0.097 | Estrogen receptor beta antagonist | |||
| 0.097 | 0.07 | 0.097 | Folate antagonist | |||
| 0.054 | 0.028 | 0.054 | Glycine transporter inhibitor | |||
| 0.043 | 0.018 | 0.043 | VCAM-1 antagonist | 0.037 0.036 CID_154699897 | ||
| 0.043 | 0.018 | 0.043 | VCAM antagonist | 0.037 0.036 CID_154699897 | ||
| 0.044 | 0.02 | 0.044 | Glucagon-like peptide 1 receptor antagonist | |||
| 0.119 | 0.095 | 0.119 | CDC-like kinase 1 inhibitor | |||
| 0.029 | 0.007 | 0.029 | ICAM 1 antagonist | |||
| 0.034 | 0.012 | 0.034 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.039 | 0.018 | 0.039 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.033 0.025 CID_154699897 | ||
| 0.12 | 0.1 | 0.122 | Mannose-6-phosphate isomerase inhibitor | 0.122 0.098 CID_154699897 0.12 0.101 CID_154699925 | CID_154699897 | |
| 0.037 | 0.019 | 0.037 | Glutamate (mGluR4) agonist | |||
| 0.122 | 0.105 | 0.122 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.212 | 0.196 | 0.271 | Calcium channel activator | 0.271 0.122 CID_154699897 0.253 0.143 CID_154699925 | CID_154699897 | |
| 0.266 | 0.249 | 0.266 | Antiinflammatory | |||
| 0.079 | 0.063 | 0.079 | Inducible nitric-oxide synthase inhibitor | |||
| 0.022 | 0.007 | 0.023 | Thyroid hormone alpha antagonist | 0.023 0.006 CID_154699897 0.021 0.007 CID_154699925 | CID_154699897 | |
| 0.023 | 0.009 | 0.023 | Retinoid X beta receptor antagonist | 0.021 0.014 CID_154699897 | ||
| 0.029 | 0.015 | 0.029 | Retinoid X gamma receptor antagonist | 0.027 0.019 CID_154699897 | ||
| 0.122 | 0.108 | 0.122 | Insulin secretagoues | |||
| 0.022 | 0.008 | 0.022 | G-protein-coupled receptor 120 agonist | 0.02 0.009 CID_154699897 0.019 0.01 CID_154699925 | ||
| 0.151 | 0.138 | 0.261 | Aldehyde oxidase inhibitor | 0.261 0.078 CID_154699897 0.254 0.081 CID_154699925 | CID_154699897 | |
| 0.038 | 0.026 | 0.038 | Retinoid X receptor antagonist | |||
| 0.086 | 0.074 | 0.086 | 5-Lipoxygenase inhibitor | |||
| 0.055 | 0.044 | 0.062 | Leukotriene C antagonist | 0.062 0.025 CID_154699925 | CID_154699925 | |
| 0.052 | 0.04 | 0.052 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.051 0.042 CID_154699897 | ||
| 0.02 | 0.008 | 0.026 | Prostacyclin agonist | 0.02 0.009 CID_154699897 0.026 0.007 CID_154699925 | CID_154699925 | |
| 0.05 | 0.039 | 0.057 | Aconitate hydratase inhibitor | 0.05 0.039 CID_154699897 0.057 0.029 CID_154699925 | CID_154699925 | |
| 0.019 | 0.008 | 0.019 | Thyroid hormone alpha agonist | 0.019 0.008 CID_154699897 0.019 0.008 CID_154699925 | ||
| 0.105 | 0.094 | 0.131 | Alpha-N-acetylglucosaminidase inhibitor | 0.105 0.094 CID_154699897 0.131 0.068 CID_154699925 | CID_154699925 | |
| 0.106 | 0.095 | 0.106 | Tubulin antagonist | |||
| 0.052 | 0.042 | 0.052 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.077 | 0.067 | 0.077 | Caspase 7 inhibitor | |||
| 0.034 | 0.024 | 0.034 | Retinoid X alpha receptor antagonist | |||
| 0.153 | 0.143 | 0.153 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.087 | 0.078 | 0.087 | Alpha 2d adrenoreceptor antagonist | |||
| 0.034 | 0.025 | 0.034 | Purinergic P2X3 antagonist | |||
| 0.109 | 0.101 | 0.109 | Antibacterial (Helicobacter pylori) | |||
| 0.059 | 0.052 | 0.059 | Beta 2 adrenoreceptor agonist | |||
| 0.194 | 0.187 | 0.237 | Vasodilator, coronary | 0.206 0.176 CID_154699897 0.237 0.148 CID_154699925 | CID_154699925 | |
| 0.064 | 0.059 | 0.068 | Exportin-1 inhibitor | 0.068 0.047 CID_154699897 | CID_154699897 | |
| 0.015 | 0.01 | 0.016 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | 0.016 0.009 CID_154699897 0.015 0.01 CID_154699925 | CID_154699897 | |
| 0.076 | 0.071 | 0.076 | NMDA receptor antagonist | |||
| 0.039 | 0.035 | 0.049 | Glutamate (mGluR group III) agonist | 0.049 0.024 CID_154699897 | CID_154699897 | |
| 0.187 | 0.183 | 0.187 | Transcription factor NF kappa B inhibitor | |||
| 0.138 | 0.136 | 0.138 | Neurotensin receptor agonist | |||
| 0.129 | 0.127 | 0.196 | Interleukin 6 antagonist | 0.196 0.043 CID_154699897 | CID_154699897 | |
| 0.046 | 0.045 | 0.046 | CD45 antagonist | |||
| 0.026 | 0.025 | 0.026 | Prostaglandin EP3 antagonist | |||
| 0.036 | 0.038 | 0.041 | Leukotriene C4 antagonist | 0.041 0.022 CID_154699925 | CID_154699925 | |
| 0.043 | 0.049 | 0.076 | Thromboxane antagonist | 0.076 0.023 CID_154699897 | CID_154699897 | |
| 0.027 | 0.038 | 0.041 | Carnitine palmitoyltransferase inhibitor | 0.041 0.015 CID_154699897 | CID_154699897 | |
| 0.034 | 0.052 | 0.061 | Thromboxane A2 antagonist | 0.061 0.028 CID_154699897 | CID_154699897 | |
| 0.038 | 0.057 | 0.047 | Carnitine palmitoyltransferase 1B inhibitor | 0.047 0.034 CID_154699897 | CID_154699897 | |
| 0.026 | 0.044 | 0.04 | Carnitine palmitoyltransferase 1 inhibitor | 0.04 0.016 CID_154699897 | CID_154699897 | |
| 0.073 | 0.104 | 0.105 | UDP-glucose 4-epimerase inhibitor | 0.105 0.055 CID_154699925 | CID_154699925 | |
| 0.045 | 0.077 | 0.073 | Phosphofructokinase-1 inhibitor | 0.073 0.045 CID_154699925 | CID_154699925 | |
| 0.124 | 0.157 | 0.139 | Ca2+-transporting ATPase inhibitor | 0.139 0.079 CID_154699925 | CID_154699925 | |
| 0.055 | 0.089 | 0.065 | Glutamate (mGluR6) antagonist | 0.065 0.051 CID_154699925 | CID_154699925 | |
| 0.068 | 0.108 | 0.088 | NADH dehydrogenase inhibitor | 0.088 0.059 CID_154699925 | CID_154699925 | |
| 0.066 | 0.112 | 0.087 | Mediator release inhibitor | 0.087 0.085 CID_154699897 | CID_154699897 | |
| 0.065 | 0.118 | 0.088 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.088 0.068 CID_154699925 | CID_154699925 | |
| 0.094 | 0.151 | 0.113 | Cell wall synthesis inhibitor | 0.113 0.111 CID_154699897 | CID_154699897 | |
| 0.142 | 0.221 | 0.207 | RNA-directed DNA polymerase inhibitor | 0.207 0.09 CID_154699925 | CID_154699925 | |
| 0.055 | 0.138 | 0.084 | Alcohol dehydrogenase inhibitor | 0.084 0.073 CID_154699897 | CID_154699897 | |
| 0.092 | 0.188 | 0.123 | Sphingosine 1-phosphate receptor 2 antagonist | 0.123 0.089 CID_154699897 | CID_154699897 | |
| 0.033 | 0.129 | 0.06 | Phenylalanine 4-hydroxylase inhibitor | 0.06 0.058 CID_154699897 | CID_154699897 | |
| 0.157 | 0.266 | 0.197 | 5 Hydroxytryptamine uptake stimulant | 0.197 0.158 CID_154699925 | CID_154699925 | |
| 0.095 | 0.226 | 0.129 | Sphingosine 1-phosphate receptor 5 antagonist | 0.129 0.102 CID_154699897 | CID_154699897 | |
| 0.101 | 0.233 | 0.268 | Tumour necrosis factor alpha release inhibitor | 0.268 0.067 CID_154699897 | CID_154699897 | |
| 0.047 | 0.267 | 0.079 | Transcription factor NF kappa B stimulant | 0.079 0.073 CID_154699925 | CID_154699925 | |
| 0.11 | 0.364 | 0.231 | Peptidyltransferase inhibitor | 0.231 0.066 CID_154699925 | CID_154699925 | |
| 0.007 | 0.739 | 0.421 | Neurotrophic factor | 0.421 0.005 CID_154699897 | CID_154699897 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |